1. Stocks
  2. PTC Therapeutics Inc
  3. Swot
swot-logo

PTC Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

PTC Therapeutics Inc has 24 Strengths, 4 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

High Normalized Momentum Score

Consistent Highest Return Stocks over Five Years - Nifty500

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Near 52 Week High

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Volume Shockers

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Book Value Per Share deteriorating for last 2 years

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Promoters increasing shareholding QoQ